diabetes meadhbh Flashcards

1
Q

what is diabetes mellitus?

A

is a group of metabolic disorders in which
persistent hyperglycaemia (random plasma glucose more than 11.1 mmol/L) is caused by deficient insulin secretion, resistance to the action of insulin, or both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the difference between type 1 and type 2 diabetes?

A

Type 1: absolute deficiency of insulin
* Type 2: insulin resistance with relative deficiency of
insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the risk factors of diabetes?

A

Obesity and inactivity; diet; family history of type 2 diabetes; Asian, African, and Afro-Caribbean ethnicity; drug treatments such as long-term corticosteroids; and history of gestational diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the complications associated with diabetes?

A

Macrovascular: CVD including ischaemic heart disease, stroke and peripheral arterial disease
* Microvascular: chronic kidney disease, retinopathy, peripheral and autonomic neuropathy
* Foot problems- ulcer, deformity, infection
* Metabolic: dyslipidaemia, potentially life-threatening hyperglycaemic emergencies (diabetic ketoacidosis and
hyperosmolar hyperglycaemic state).
* Psychosocial impact: anxiety, depression, eating disorders, behavioural and emotional problems.
* Reduced life expectancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what lifestyle advice should be given to patient with diabetes?

A

diet, exercise, weight management
* Refer to retinal screening programme
* Annual foot checks
* Alcohol
* Smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is type 1 diabetes?

A

Metabolic disorder characterised by hyperglycaemia due to
absolute insulin deficiency.
* The condition develops due to destruction of pancreatic beta
cells, mostly by immune-mediated mechanisms.
* Without insulin replacement, people with type 1 diabetes
would die within days or weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how do you diagnose type 1 diabetes?

A

– hyperglycaemia random plasma glucose ≥11.1 mmol/L AND characteristic features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the typical signs of type 1 diabetes?

A

– ketosis
– rapid weight loss
– age of onset under 50
– body mass index (BMI) below 25 kg/m2
– personal and/or family history of autoimmune disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the targets for type 1 diabetes?

A

– Aim for HbA1c level of 48 mmol/mol (6.5%) or lower, to minimise the
risk of long-term vascular complications.
– Ensure HbA1c target is not accompanied by hypoglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the 3 different types of insulin regimens?

A

1,2,or 3 insulin injections per day
multiple daily injection
continuous subcutaneous insulin infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how does MDI regime work?

A

– Rapid- or short-acting insulin before meals
AND
– One or more separate daily injections of intermediate- or long-acting insulin analogue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how does CSII regime work?

A

– Portable electromechanical pump that gives basal infusion & individual bolus doses when required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is first line insulin therapy?

A

Multiple daily injection basal–bolus insulin regimen
– Twice-daily insulin detemir as basal insulin
– Or
* Once-daily insulin glargine if insulin detemir is not tolerated or preference for once-daily basal injections
* Once-daily insulin degludec if concern about nocturnal hypoglycaemia or if need healthcare professional/ carer to administer
* AND Rapid-acting insulin analogues that are injected before meal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how often should you monitor blood glucose for type 1?

A
  • Blood glucose monitor, lancets and test strips
  • Routine self monitoring at least 4/day including before meals and bed
  • Increase monitoring during illness, sport, driving, pregnant, frequent
    hypoglycaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the targets for blood glucose monitoring?

A

waking- 5-7mmol/L
before meals+ other times of day- 4-7 mmol/L
after meals-90min- 5-9mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how do you flash monitor?

A

– Sensor on arm which lasts 14 days.
– Flexible and sterile fibre within the sensor is inserted in the skin to a depth of
5 mm.
– Draws interstitial fluid from the muscle into the sensor, where glucose levels are
automatically measured every minute and stored at 15-minute intervals for
8 hours
– Scan with smartphone app or meter reader
– Current glucose reading, previous 8 hours, trend
– Optional alarms for hypo/ hyperglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how do you continouus glucose monitor?

A

– Continuous glucose monitor.
– Sends signal to device/ mobile via bluetooth at 5-minute intervals.
– Sensor 10-14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is hypoglycaemia?

A

When blood glucose levels fall to less than 3.5 mmol/L
* Levels where signs and symptoms appear may vary
* Cognitive function deteriorates when blood glucose levels fall to less than 3.0 mmol/L.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the signs of hypoglycaemia?

A

hunger, anxiety, palpitations, sweating, tingling lips, weakness, leathery, visual disturbances, confusion, convulsions, loss of consciousness, coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

how do you manage hypoglycaemia?

A
  1. 10–20 g of a fast-acting form of carbohydrate, preferably in liquid form as
    this is easier to take– 3–6 glucose tablets
  2. Recheck blood glucose levels after 10–15 minutes
    – No response or an inadequate response, repeat as above and re-test blood
    glucose levels after another 15 minutes
  3. If the person is unconscious and unable to swallow (severe hypoglycaemia):
    – Intramuscular (IM) glucagon should be administered immediately.
    * Adults - 1 mg of glucagon should be given.
    – If no response to glucagon treatment within 10 minutes, emergency transfer
    to hospital should be arranged for treatment with IV glucose.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is hba1c?

A

Measure of glycosylated haemoglobin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the aim for the hba1c?

A

Aim for HbA1c <48mmol/mol without disabling hypoglycaemia in type 1 diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

why is the target for the Hba1c set around that?

A

Targets set around balance between risk of hypoglycaemia & risk of long-term vascular complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

how often should you test Hba1c levels?

A

every 3-6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what are the limitations of Hba1c?

A
  • Not used for diagnosis in the following groups
    – <18 years
    – Type 1 diabetes suspected or symptoms <2 months
    – Medication that can cause hyperglycaemia (corticosteroids)
    – Acute pancreatic damage, end stage renal disease, HIV
  • Interpret with caution if abnormal red blood cell turnover
    – Severe anaemia, recent transfusion
26
Q

what is type 2 diabetes associated with?

A

Associated with obesity, physical inactivity, hypertension, disturbed blood lipid levels and increased cardiovascular risk

27
Q

what are the clinical features of type 2 diabetes?

A

Polydipsia, polyuria, blurred vision, unexplained weight loss, recurrent
infections, and tiredness, acanthosis nigricans.

28
Q

how do you diagnose type 2 diabetes?

A
  • HbA1c of 48 mmol/mol (6.5%) or more.
  • Fasting plasma glucose level of 7.0 mmol/L or more.
  • Random plasma glucose of 11.1 mmol/L or more in the presence of
    symptoms or signs of diabetes.
  • No additional features of type 1 diabetes (rapid onset, often in
    childhood, insulin dependence, ketoacidosis).
29
Q

what are glucose lowering agents used in type 2 diabetes?

A

biguanide- metformin
sulfunurea- gluclazide
SGLT2 Inhibitors- dapagliflozin
DPP4 inhibitors- gliptins
GLP-1 -exenatide
insulin- human insulin
thiazolidinedione-pioglitazone

30
Q

what are the benefits of metformin?

A

CV protection
Moderately-effective
glycaemic control
Hypo risk: low
Weight: neutral to loss
Cost effective

31
Q

what are the risks of using metformin?

A

Caution in renal
impairment.
Max 1g <45mL/min.
Stop <30mL/min
Lactic acidosis :

32
Q

what are the benefits of using sulfonylureas?

A

High glucose
lowering efficacy
CV neutral
Cost effective

33
Q

what are the risks for sulfonylureas?

A

Hypo risk: HIGH
Weight GAIN
Caution in renal
impairment- increased
hypo risk

34
Q

what are the benefits of DPP-4 inhibitors?

A

Hypo risk: LOW
Weight: neutral
Linagliptin no dose
reduction in renal
impairment

35
Q

what are the risks of DPP-4 inhibitors?

A

Least effective
glycaemic control
Pancreatitis
Cancer?
IBD and heart failure
Pancreatitis: report persistent
severe abdominal pain.
Cholangiocarcinoma: increased
risk (almost double) but very
rare disease
IBD and HF? Possible risk

36
Q

what are the benefits of GLP-1 inhibitors?

A

Weight: LOSS
Highly-effective
glycaemic control
CV and renal
benefits

37
Q

what are the risks of GLP-1 mimetics?

A

Pancreatitis
Expensive
Cancer?

38
Q

what is the benefit of pioglitazone?

A

Moderate glycaemic
control
Hypo risk: LOW
Safe in renal
impairment
Cost effective

39
Q

what are the risks of pioglitazone?

A

Heart failure
Weight GAIN
Cancer
Fracture

40
Q

how should you review the risks of pioglitazone?

A

Review at 3-6 months and continue only if benefits outweigh risk
* Heart failure: contraindicated in heart failure and can increase the risk of
developing heart failure in patients with risk factors: insulin or history of MI
* Bladder cancer: contraindicated if history of bladder cancer.
* Report haematuria, dysuria, urinary urgency.
* Risk factors: increased age, smoker, previous radiation to bladder.

41
Q

what are the benefits of SGLT2 inhibitors?

A

CV and Renal
benefits
Weight: neutral to loss
Hypo risk: LOW
Moderate
glycaemic control

42
Q

what are the risks of SGLT2 inhibitors?

A

Urinary and genital inf
Diabetic ketoacidosis
Lower limb
amputation
Fournier’s gangrene
Renal impairment?

43
Q

what are the signs of DKA?

A
  • Report rapid weight loss, nausea or vomiting, ab pain, fast breathing, sleepiness,
    sweet smelling breath/ metallic taste. Discontinue if suspected and do not restart.
  • Test for ketones even if blood sugar only mildly raised (>14mmol/L)
  • Risk factor: low beta cell reserve, dehydration, acute illness, alcohol abuse. Monitor
    ketones during surgery
44
Q

what is first line insulin for type 2 diabetes?

A

NPH (isophane) insulin injected once or twice daily according to need

45
Q

when should NPH+ short acting insulin be considered?

A

– If HbA1c is 75 mmol/mol or higher, to be administered either separately or as a pre-mixed (biphasic) human insulin preparation.

46
Q

when should you consider insulin deteminr or insulin glargine?

A

– Carer or healthcare professional injects insulin, and the use of insulin
detemir or insulin glargine would reduce the frequency of injections
from twice to once daily
– The person’s lifestyle is restricted by recurrent symptomatic
hypoglycaemic episodes, or
– The person would otherwise need twice-daily NPH insulin injections in
combination with oral antidiabetic drugs.

47
Q

what are the sick day rules?

A
  • If persistent vomiting or diarrhoea
    – Withhold
  • Metformin due to risk of lactic acidosis
  • SGLT2i due to risk of DKA
  • Restart only AFTER patient has been eating normally for AT LEAST
    24 HOURS AND no longer acutely unwell
    – Insulin- increase monitoring, do not stop
    – Sulfonylurea- monitor blood glucose for symptoms of
    hypoglycaemia
  • Drink plenty of fluids
48
Q

what are the CV risk factors for type 2 diabetes?

A

– QRISK: primary prevention- atorvastatin 20mg if >10%
– All people with CKD stage 3 or more and/or confirmed urine
microalbuminuria, should be offered atorvastatin 20 mg once daily,
irrespective of lipid profile.
– Now also factors into decision making for diabetes treatment

49
Q

what is the cv risk for type 1 diabetes?

A

– Offer statin treatment with atorvastatin 20 mg for the primary
prevention of CVD if the person:
* Is older than 40 years of age, or
* Has had diabetes for more than 10 years, or
* Has established nephropathy, or
* Has other CVD risk factors (such as obesity and hypertension).

50
Q

what is first line treatment for hypertension with type 2 diabetes?

A

– Differences: ACEi first line
* ARB preferred if African or African-Caribbean origin

51
Q

what is the guidelines for hypertension and type 1 diabetes?

A

– No albuminuria or features of the metabolic syndrome, start antihypertensive treatment in if BP ≥135/85 mmHg.
– Albuminuria or two or more features of the metabolic syndrome, start antihypertensive treatment if BP ≥130/80 mmHg.
– ACEi first line
* ARB preferred if African or African-Caribbean origin

52
Q

what is an early indicator of diabetic nephropathy?

A

Microalbuminuria

53
Q

what are the limits for ARC ratio?

A

– First-pass morning urine specimen
– If ACR is 3 mg/mmol or more start ACEi or ARB and titrate to
highest tolerated dose
– If ACR 3-30 mg/mmol consider SGLT2i.
– If ACR >30 mg/mmol offer SGLT2i
* Not all SGLT2i licensed. Dapagliflozin licensed

54
Q

what is DKA?

A

Life-threatening emergency
* Metabolic triad of hyperglycaemia,
ketonaemia, and metabolic acidosis, with
rapid symptom onset.
* Mainly type 1 diabetes, SGLT2i increases
risk in type 2

55
Q

What are the landmarks for DKA?

A

glucose>11mmol/l or known
diabetic
ketone >3.0 mmol/L or significant
ketonuria
bicarbonate concentration of <15.0 mmol/L or
venous pH <7.3

56
Q

what are the causes of DKA?

A

– Infection, inadequate insulin, new onset diabetes, medication (SGLT2i,
corticosteroids)
– Insulin deficiency + increase in counter regulatory hormones e.g. glucagon,
cortisol, growth hormone and catecholamines
– Enhanced gluconeogenesis and glycogenolysis causing severe hyperglycaemia
– Increased lipolysis and metabolism of free fatty acids resulting in ketogenesis-
Increased ketones
– Subsequent metabolic acidosis
– Fluid depletion and electrolyte disturbances

57
Q

what are the symptoms of DKA?

A

– Rapid presentation of polyuria, polydipsia, rapid weight loss, nausea or vomiting,
ab pain, fast breathing, sleepiness, sweet smelling breath/ metallic taste,
reduced consciousness.
– May be delayed in type 2 diabetes

58
Q

how do you treat DKA?

A

– Fluid replacement- correct hypotension, counteract osmotic diuresis and
correct electrolyte disturbances. Potassium to prevent hypokalaemia
* NaCl 0.9% by IV infusion, with potassium chloride adjusted according to plasma levels
– Fixed rate insulin infusion 0.1 unit/kg/hour based on estimated weight made
up to 50mL with 0.9% NaCl
* If patient takes long-acting insulin analogue- continue
* If blood glucose falls <14mmol/L add 10% glucose to prevent rebound hypoglycaemia
* Consider reducing insulin to 0.05units/kg/hr when glucose <14 mmol/L

59
Q

how do you monitor DKA?

A

– Hourly capillary glucose and ketones
– Bicarbonate and potassium at 60 mins, 2 hours and then 2 hourly
– U+E (4 hourly) and FBC
– BP, pulse, temperature, oxygen saturation
– Further Ix: blood culture, ECG, CXR, MSU

60
Q

when is surgery needed in diabetes?

A

Elective surgery—minor procedures in patients with good glycaemic control
* Good glycaemic control (HbA1c less than 69 mmol/mol)
* Managed during the operative period by adjustment of their usual
insulin regimen

61
Q

how should insulin be given on a day of surgery?

A

On the day before the surgery, the patient’s usual insulin should be
given as normal, other than lunchtime and evening once daily long-
acting insulin analogues, which should be given at a dose reduced by
20 %. If it is given in the morning- no need to reduce dose
Major surgery/poor glycaemic control….more complicated